{
  "context": {
    "rules": [
      "Rule1: If drug Y is effective, then material X is safe.",
      "Rule2: In the event that drug Y is recalled, it is hazardous.",
      "Rule3: Either drug Y is recalled or drug Y is reformulated.",
      "Rule4: Should drug Y be reformulated, material X is safe.",
      "Rule5: If region Alpha is monitored by organization Beta, then if it is not the case that drug Y being recalled implies material X is safe, drug Y is investigated by organization Beta.",
      "Rule6: In the scenario where organization Beta is penalized in region Alpha, then if organization Beta is audited in region Alpha, material X is not approved in region Alpha.",
      "Rule7: Either organization Beta is settled in region Alpha or organization Beta is not appealed in region Alpha.",
      "Rule8: Provided that drug Y is safe, material X is safe.",
      "Rule9: If drug Y is tested by organization Beta, then drug Y is safe.",
      "Rule10: Whenever legislation Gamma is amended in region Alpha, it is compliant in region Alpha.",
      "Rule11: Legislation Gamma is suspended in region Alpha or, if legislation Gamma is enforced in region Alpha, then it is amended in region Alpha.",
      "Rule12: Material X is tested by organization Beta or material X is restricted in region Alpha.",
      "Rule13: Provided that material X is restricted in region Alpha, it is not approved in region Alpha.",
      "Rule14: In the case that material X is certified by organization Beta, then if material X is tested by organization Beta, material X is banned in region Alpha.",
      "Rule15: Either material X is certified by organization Beta or material X is validated by organization Beta.",
      "Rule16: Should material X be validated by organization Beta, then if material X is tested by organization Beta, material X is banned in region Alpha.",
      "Rule17: If drug Y is manufactured by organization Beta, then drug Y is available in region Alpha.",
      "Rule18: Drug Y is manufactured by organization Beta or drug Y is distributed in region Alpha.",
      "Rule19: Provided that drug Y is distributed in region Alpha, it is effective.",
      "Rule20: Whenever drug Y is distributed in region Alpha, it is tested by organization Beta.",
      "Rule21: If it is not the case that legislation Gamma being enforced in region Alpha implies it is compliant in region Alpha, then legislation Gamma is violated in region Alpha.",
      "Rule22: In the scenario where it is not the case that legislation Gamma being enforced in region Alpha implies it is compliant in region Alpha, then legislation Gamma is not violated in region Alpha.",
      "Rule23: If it is not the case that drug Y being hazardous implies material X is safe, then drug Y is banned in region Alpha.",
      "Rule24: If it is not the case that the negation of (drug Y being hazardous implies material X is safe) implies drug Y is not banned in region Alpha, then organization Beta is litigated in region Alpha.",
      "Rule25: Should organization Beta not be penalized in region Alpha, then organization Beta is appealed in region Alpha.",
      "Rule26: In the case that material X is not safe, then material X is approved in region Alpha.",
      "Rule27: If material X is not safe, then legislation Gamma is enforced in region Alpha."
    ],
    "facts": [
      "Fact1: Region Alpha is monitored by organization Beta.",
      "Fact2: Organization Beta is audited in region Alpha.",
      "Fact3: Legislation Gamma is not compliant in region Alpha.",
      "Fact4: Drug Y is not investigated by organization Beta.",
      "Fact5: Material X is not banned in region Alpha.",
      "Fact6: Organization Beta is not settled in region Alpha.",
      "Fact7: Legislation Gamma is not suspended in region Alpha.",
      "Fact8: Organization Beta is not litigated in region Alpha.",
      "Fact9: Drug Y is not available in region Alpha."
    ]
  },
  "question": "Material X is safe."
}